Impact of treatment sequence on the outcomes of metastatic castration resistant prostate cancer patients (mCRPC) with germline BRCA2 mutations: A subanalysis of the PROREPAIR-B study
Abstract only
Saved in:
Published in | Journal of clinical oncology Vol. 36; no. 15_suppl; p. 5071 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
20.05.2018
|
Online Access | Get full text |
Cover
Loading…
Summary: | Abstract only |
---|---|
ISSN: | 0732-183X 1527-7755 |
DOI: | 10.1200/JCO.2018.36.15_suppl.5071 |